{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:39Z","timestamp":1761864759658,"version":"3.44.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(U21A20411)"],"award-info":[{"award-number":["(U21A20411)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan University of Chinese Medicine Disciplinary Construction' Revealing the List and Appointing Leaders' Project","award":["(22JBZ002)"],"award-info":[{"award-number":["(22JBZ002)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04519-w","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:55:00Z","timestamp":1745229300000},"page":"3373-3385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of the gut microbiome with diabetic nephropathy and the mediated effect of metabolites: friend or enemy?"],"prefix":"10.1007","volume":"57","author":[{"given":"Yunfeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuman","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"4519_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9841-8_1","author":"MK Sagoo","year":"2020","unstructured":"Sagoo MK, Gnudi L (2020) Diabetic nephropathy: an overview. Methods Mol Biol. https:\/\/doi.org\/10.1007\/978-1-4939-9841-8_1","journal-title":"Methods Mol Biol"},{"key":"4519_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1497449","author":"N Samsu","year":"2021","unstructured":"Samsu N (2021) Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. https:\/\/doi.org\/10.1155\/2021\/1497449","journal-title":"Biomed Res Int"},{"key":"4519_CR3","doi-asserted-by":"publisher","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"4519_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14007","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW (2020) An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obesity Metabol. https:\/\/doi.org\/10.1111\/dom.14007","journal-title":"Diabetes Obesity Metabol"},{"key":"4519_CR5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. https:\/\/doi.org\/10.2215\/CJN.11491116","journal-title":"Clin J Am Soc Nephrol"},{"key":"4519_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.029","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. https:\/\/doi.org\/10.1016\/j.diabres.2011.10.029","journal-title":"Diabetes Res Clin Pract"},{"key":"4519_CR7","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666201029143606","author":"J Ji","year":"2021","unstructured":"Ji J, Tao P, Wang Q, Li L, Xu Y (2021) SIRT1: mechanism and protective effect in diabetic nephropathy. Endocr Metab Immune Disord Drug Targets. https:\/\/doi.org\/10.2174\/1871530320666201029143606","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4519_CR8","doi-asserted-by":"publisher","DOI":"10.1159\/000489913","author":"K Wang","year":"2018","unstructured":"Wang K, Hu J, Luo T, Wang Y, Yang S, Qing H, Cheng Q, Li Q (2018) Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: a systematic review and meta-analysis. Kidney Blood Press Res. https:\/\/doi.org\/10.1159\/000489913","journal-title":"Kidney Blood Press Res"},{"key":"4519_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12567","author":"JM Pickard","year":"2017","unstructured":"Pickard JM, Zeng MY, Caruso R, N\u00fa\u00f1ez G (2017) Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. https:\/\/doi.org\/10.1111\/imr.12567","journal-title":"Immunol Rev"},{"key":"4519_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1756-4","author":"YY Chen","year":"2019","unstructured":"Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, Zhao YY (2019) Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-018-1756-4","journal-title":"J Transl Med"},{"key":"4519_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00324-22","volume":"10","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Z, Zhang X, Zhao L, Chu J, Li H, Sun W, Yang C, Wang H, Dai W, Yan S, Chen X, Xu D (2022) Alterations of the gut microbiota in patients with diabetic nephropathy. Microbiol Spectr 10:e0032422. https:\/\/doi.org\/10.1128\/spectrum.00324-22","journal-title":"Microbiol Spectr"},{"key":"4519_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00575","author":"B Zhou","year":"2020","unstructured":"Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li G, Xiong W, Zeng Z (2020) Intestinal flora and disease mutually shape the regional immune system in the intestinal tract. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00575","journal-title":"Front Immunol"},{"key":"4519_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116257","author":"C Han","year":"2023","unstructured":"Han C, Shen Z, Cui T, Ai SS, Gao RR, Liu Y, Sui GY, Hu HZ, Li W (2023) Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the \u201cgut-kidney axis.\u201d J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2023.116257","journal-title":"J Ethnopharmacol"},{"key":"4519_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2226925","author":"G Fan","year":"2023","unstructured":"Fan G, Cao F, Kuang T, Yi H, Zhao C, Wang L, Peng J, Zhuang Z, Xu T, Luo Y et al (2023) Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2023.2226925","journal-title":"Gut Microbes"},{"key":"4519_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1039711","author":"CG Ju","year":"2022","unstructured":"Ju CG, Zhu L, Wang W, Gao H, Xu YB, Jia TZ (2022) Cornus officinalis prior and post-processing: Regulatory effects on intestinal flora of diabetic nephropathy rats. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1039711","journal-title":"Front Pharmacol"},{"key":"4519_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg070","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S (2003) \u201cmendelian randomization\u201d: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. https:\/\/doi.org\/10.1093\/ije\/dyg070","journal-title":"Int J Epidemiol"},{"key":"4519_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA. https:\/\/doi.org\/10.1001\/jama.2017.17219","journal-title":"JAMA"},{"key":"4519_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"JAMA"},{"key":"4519_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00992-y","author":"VW Skrivankova","year":"2022","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N et al (2022) Effect of host genetics on the gut microbiome in 7738 participants of the Dutch Microbiome Project. Nat Genet. https:\/\/doi.org\/10.1038\/s41588-021-00992-y","journal-title":"Nat Genet"},{"key":"4519_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01270-1","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, Cerani A, Liang KYH, Yoshiji S, Willett JDS et al (2023) Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. https:\/\/doi.org\/10.1038\/s41588-022-01270-1","journal-title":"Nat Genet"},{"key":"4519_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. https:\/\/doi.org\/10.1038\/s41586-022-05473-8","journal-title":"Nature"},{"key":"4519_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106858119","author":"X Hu","year":"2022","unstructured":"Hu X, Zhao J, Lin Z, Wang Y, Peng H, Zhao H, Wan X, Yang C (2022) Mendelian randomization for causal inference accounting for pleiotropy and sample structure using genome-wide summary statistics. Proc Natl Acad. https:\/\/doi.org\/10.1073\/pnas.2106858119","journal-title":"Proc Natl Acad"},{"key":"4519_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165764","author":"Y Li","year":"2020","unstructured":"Li Y, Su X, Gao Y, Lv C, Gao Z, Liu Y, Wang Y, Li S, Wang Z (2020) The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment. Biochim Biophys Acta Mol Basis Dis. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165764","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4519_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnac072","author":"Y Cui","year":"2022","unstructured":"Cui Y, Zhang L, Wang X, Yi Y, Shan Y, Liu B, Zhou Y, L\u00fc X (2022) Roles of intestinal Parabacteroides in human health and diseases. FEMS Microbiol Lett. https:\/\/doi.org\/10.1093\/femsle\/fnac072","journal-title":"FEMS Microbiol Lett"},{"key":"4519_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908219","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhao J, Qin Y, Yu Z, Zhang Y, Ning X, Sun S (2022) The specific alteration of gut microbiota in diabetic kidney diseases-A systematic review and meta-analysis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.908219","journal-title":"Front Immunol"},{"key":"4519_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/genes14081572","author":"R Li","year":"2023","unstructured":"Li R, Shokri F, Rincon AL, Rivadeneira F, Medina-Gomez C, Ahmadizar F (2023) Bi-directional interactions between glucose-lowering medications and gut microbiome in patients with type 2 diabetes mellitus: a systematic review. Genes. https:\/\/doi.org\/10.3390\/genes14081572","journal-title":"Genes"},{"key":"4519_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00382-23","author":"L Zhang","year":"2023","unstructured":"Zhang L, Lu QY, Wu H, Cheng YL, Kang J, Xu ZG (2023) The intestinal microbiota composition in early and late stages of diabetic kidney disease. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.00382-23","journal-title":"Microbiol Spectr"},{"key":"4519_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072131","author":"S Zheng","year":"2021","unstructured":"Zheng S, Wang Y, Fang J, Geng R, Li M, Zhao Y, Kang SG, Huang K, Tong T (2021) Oleuropein ameliorates advanced stage of type 2 diabetes in db\/db mice by regulating gut microbiota. Nutrients. https:\/\/doi.org\/10.3390\/nu13072131","journal-title":"Nutrients"},{"key":"4519_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.877914","author":"H Yan","year":"2022","unstructured":"Yan H, Qin Q, Yan S, Chen J, Yang Y, Li T, Gao X, Ding S (2022) Comparison of the gut microbiota in different age groups in China. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2022.877914","journal-title":"Front Cell Infect Microbiol"},{"key":"4519_CR30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402598","author":"S Guo","year":"2015","unstructured":"Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY (2015) Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1402598","journal-title":"J Immunol"},{"key":"4519_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161635","author":"X Ling","year":"2016","unstructured":"Ling X, Linglong P, Weixia D, Hong W (2016) Protective effects of bifidobacterium on intestinal barrier function in LPS-induced enterocyte barrier injury of Caco-2 monolayers and in a rat NEC model. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0161635","journal-title":"PLoS One"},{"key":"4519_CR32","doi-asserted-by":"publisher","DOI":"10.2741\/3413","author":"R Al-Sadi","year":"2009","unstructured":"Al-Sadi R, Boivin M, Ma T (2009) Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci. https:\/\/doi.org\/10.2741\/3413","journal-title":"Front Biosci"},{"key":"4519_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.03.242","author":"Y Feng","year":"2019","unstructured":"Feng Y, Weng H, Ling L, Zeng T, Zhang Y, Chen D, Li H (2019) Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.03.242","journal-title":"Int J Biol Macromol"},{"key":"4519_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01219-9","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, Liu MD, Zhou HL, Wang YS, Xu ZX (2023) Short-chain fatty acids in diseases. Cell Commun Signal. https:\/\/doi.org\/10.1186\/s12964-023-01219-9","journal-title":"Cell Commun Signal"},{"key":"4519_CR35","doi-asserted-by":"publisher","unstructured":"Stachowska E, Wi\u015bniewska M, Dzie\u017cyc A, Bohatyrewicz A (2021) Could the use of butyric acid have a positive effect on microbiota and treatment of type 2 diabetes? Eur Rev Med Pharmacol https:\/\/doi.org\/10.26355\/eurrev_202107_26250","DOI":"10.26355\/eurrev_202107_26250"},{"key":"4519_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03002-1","author":"K Cai","year":"2022","unstructured":"Cai K, Ma Y, Cai F, Huang X, Xiao L, Zhong C, Ren P, Luo Q, Chen J, Han F (2022) Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury. Endocrine. https:\/\/doi.org\/10.1007\/s12020-022-03002-1","journal-title":"Endocrine"},{"key":"4519_CR37","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-121493","author":"W Huang","year":"2017","unstructured":"Huang W, Guo HL, Deng X, Zhu TT, Xiong JF, Xu YH, Xu Y (2017) Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide. Exp Clin Endocrinol Diabetes. https:\/\/doi.org\/10.1055\/s-0042-121493","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4519_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4074832","author":"W Huang","year":"2020","unstructured":"Huang W, Man Y, Gao C, Zhou L, Gu J, Xu H, Wan Q, Long Y, Chai L, Xu Y et al (2020) Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-\u03baB signaling. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2020\/4074832","journal-title":"Oxid Med Cell Longev"},{"key":"4519_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.055","author":"A Koh","year":"2018","unstructured":"Koh A, Molinaro A, St\u00e5hlman M, Khan MT, Schmidt C, Manner\u00e5s-Holm L, Wu H, Carreras A, Jeong H, Olofsson LE et al (2018) Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. https:\/\/doi.org\/10.1016\/j.cell.2018.09.055","journal-title":"Cell"},{"key":"4519_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.01.012","author":"TI Krisko","year":"2020","unstructured":"Krisko TI, Nicholls HT, Bare CJ, Holman CD, Putzel GG, Jansen RS, Sun N, Rhee KY, Banks AS, Cohen DE (2020) Dissociation of adaptive thermogenesis from glucose homeostasis in microbiome-deficient mice. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2020.01.012","journal-title":"Cell Metab"},{"key":"4519_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.977187","author":"Q Lv","year":"2022","unstructured":"Lv Q, Li Z, Sui A, Yang X, Han Y, Yao R (2022) The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.977187","journal-title":"Front Microbiol"},{"key":"4519_CR42","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.121.000408","author":"M Dambrova","year":"2022","unstructured":"Dambrova M, Makrecka-Kuka M, Kuka J, Vilskersts R, Nordberg D, Attwood MM, Smesny S, Sen ZD, Guo AC, Oler E et al (2022) Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials. Pharmacol Rev. https:\/\/doi.org\/10.1124\/pharmrev.121.000408","journal-title":"Pharmacol Rev"},{"key":"4519_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22846","author":"R Klepochov\u00e1","year":"2020","unstructured":"Klepochov\u00e1 R, Leutner M, Bastian M, Krebs M, Weber M, Trattnig S, Kautzky-Willer A, Kr\u0161\u0161\u00e1k M (2020) Muscle-specific relation of acetylcarnitine and intramyocellular lipids to chronic hyperglycemia: a pilot 3-T 1H MRS study. Obesity. https:\/\/doi.org\/10.1002\/oby.22846","journal-title":"Obesity"},{"key":"4519_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097761","author":"T Auguet","year":"2023","unstructured":"Auguet T, Bertran L, Capellades J, Abell\u00f3 S, Aguilar C, Sabench F, Del Castillo D, Correig X, Yanes O, Richart C (2023) LC\/MS-based untargeted metabolomics analysis in women with morbid obesity and associated type 2 diabetes mellitus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24097761","journal-title":"Int J Mol Sci"},{"key":"4519_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002733","author":"C Sikorski","year":"2022","unstructured":"Sikorski C, Azab S, de Souza RJ, Shanmuganathan M, Desai D, Teo K, Atkinson SA, Morrison K, Gupta M, Britz-McKibbin P et al (2022) Serum metabolomic signatures of gestational diabetes in South Asian and white European women. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002733","journal-title":"BMJ Open Diabetes Res Care"},{"key":"4519_CR46","doi-asserted-by":"publisher","unstructured":"Hallan SI, \u00d8vrehus MA, Darshi M, Montemayor D, Langlo KA, Bruheim P, Sharma K (2023) Metabolic differences in diabetic kidney disease patients with normoalbuminuria versus moderately increased albuminuria. Kidney https:\/\/doi.org\/10.34067\/KID.0000000000000248","DOI":"10.34067\/KID.0000000000000248"},{"key":"4519_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(85)90015-3","author":"U Andrae","year":"1985","unstructured":"Andrae U, Singh J, Ziegler-Skylakakis K (1985) Pyruvate and related alpha-ketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxicity. Toxicol Lett. https:\/\/doi.org\/10.1016\/0378-4274(85)90015-3","journal-title":"Toxicol Lett"},{"key":"4519_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-015-9686-9","author":"CP Mescka","year":"2015","unstructured":"Mescka CP, Guerreiro G, Donida B, Marchetti D, Wayhs CA, Ribas GS, Coitinho AS, Wajner M, Dutra-Filho CS, Vargas CR (2015) Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-015-9686-9","journal-title":"Metab Brain Dis"},{"key":"4519_CR49","doi-asserted-by":"publisher","unstructured":"Wu N, Ma YC, Gong XQ, Zhao PJ, Jia YJ, Zhao Q, Duan JH, Zou CG (2023) The metabolite alpha-ketobutyrate extends lifespan by promoting peroxisomal function in C. elegans. Nat Commun https:\/\/doi.org\/10.1038\/s41467-023-35899-1","DOI":"10.1038\/s41467-023-35899-1"},{"key":"4519_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26037","author":"M Gur","year":"2022","unstructured":"Gur M, Zuckerman-Levin N, Masarweh K, Hanna M, Laghi L, Marazzato M, Levanon S, Hakim F, Bar-Yoseph R, Wilschanski M (2022) The effect of probiotic administration on metabolomics and glucose metabolism in CF patients. Pediatr Pulmonol. https:\/\/doi.org\/10.1002\/ppul.26037","journal-title":"Pediatr Pulmonol"},{"key":"4519_CR51","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0570","author":"C Menni","year":"2013","unstructured":"Menni C, Fauman E, Erte I, Perry JR, Kastenm\u00fcller G, Shin SY, Petersen AK, Hyde C, Psatha M, Ward KJ et al (2013) Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. https:\/\/doi.org\/10.2337\/db13-0570","journal-title":"Diabetes"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04519-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:00:25Z","timestamp":1758808825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04519-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4519"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04519-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors hereby state that the study has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study is based on published experimental research and is not currently applicable to medical ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics in publishing"}}]}}